Table 1. Resistance factor of DRC and SCC to anti-cancer agents.

Drugs	Hep3B (IC50)	DRC (IC50)	SCC (IC50)	DRC/Hep3B(resistance fold)	SCC/Hep3B (resistance fold)	DRC/SCC (resistance fold)
Vinblastine	8.59 nM	482 nM	126 nM	56.11	14.66	3.82
Methotraxate	8.6 µM	281 µM	86 µM	32.67	10.00	3.26
Doxorubicin	3.5 nM	160 nM	31 nM	45.71	8.85	5.16
Cisplatin	4.0 µM	15 µM	10 µM	3.75	2.50	1.50